Cargando…
Association of COVID-19 with hepatic metabolic dysfunction
The coronavirus disease 2019 (COVID-19) pandemic continues to be a global problem with over 438 million cases reported so far. Although it mostly affects the respiratory system, the involvement of extrapulmonary organs, including the liver, is not uncommon. Since the beginning of the pandemic, metab...
Autores principales: | Kumar, Ramesh, Kumar, Vijay, Arya, Rahul, Anand, Utpal, Priyadarshi, Rajeev Nayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523326/ https://www.ncbi.nlm.nih.gov/pubmed/36188741 http://dx.doi.org/10.5501/wjv.v11.i5.237 |
Ejemplares similares
-
Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism
por: Arya, Rahul, et al.
Publicado: (2023) -
Chronic renal dysfunction in cirrhosis: A new frontier in hepatology
por: Kumar, Ramesh, et al.
Publicado: (2021) -
Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications
por: Kumar, Ramesh, et al.
Publicado: (2021) -
Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations
por: Kumar, Ramesh, et al.
Publicado: (2019) -
Sarcopenia in Chronic Liver Disease: A Metabolic Perspective
por: Kumar, Ramesh, et al.
Publicado: (2022)